EMA approves Flutiform for children with asthma
The European Medicines Agency (EMA) has approved Flutiform pMDI for use in the treatment of children with asthma aged five years and over.
Read More
Tag: flutiform
UK first EU nation to launch flutiform k-haler for asthma
Napp Pharmaceuticals says the UK is the first country in Europe to launch flutiform k-haler, a breath-actuate inhaler for adolescents and adults living with asthma.
Read More
Flutiform fails to hit targets in COPD trial
UK group Vectura saw its shares drop 10 percent after partner Munipharma reported that respiratory drug flutiform failed to hit targets in a late-stage trial involving patients with chronic obstructive pulmonary disease.
Read More
- UKHSA and ICL confirm variant which plays key role in global surge of Strep A infections
- Study reveals heart failure device could monitor patients and prevent hospitalisation
- MIT’s new MRI brain light-detecting technique could support brain cell studies
- PharmaTimes MSEA and NIEA awards are open for entry
- BBSRC invests £48m in Babraham Institute to advance lifelong health research
